Angiotensin II type 1 receptor blockers reduce tissue factor activity and plasminogen activator inhibitor type-1 antigen in hypertensive patients: a randomized, double-blind, placebo-controlled study - Koh, KK; Chung, WJ; Ahn, JY (Atherosclerosis, 2004)
et al.